• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Clovis Oncology

Anonymous board for Clovis Oncology
Replies
6
Views
1K
anonymous
Replies
44
Views
8K
anonymous
Replies
74
Views
11K
anonymous
Replies
9
Views
2K
anonymous
Replies
4
Views
3K
anonymous
Replies
1
Views
685
anonymous
Replies
21
Views
4K
anonymous
Replies
10
Views
2K
anonymous